Hepatitis C in Developing Countries

Produk Detail:
  • Author : Sanaa M. Kamal
  • Publisher : Academic Press
  • Pages : 278 pages
  • ISBN : 0128032340
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Hepatitis C in Developing Countries

Download or Read online Hepatitis C in Developing Countries full in PDF, ePub and kindle. this book written by Sanaa M. Kamal and published by Academic Press which was released on 23 November 2017 with total page 278 pages. We cannot guarantee that Hepatitis C in Developing Countries book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1. Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinoma Presents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6 Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C

Hepatitis C in Developing Countries

Hepatitis C in Developing Countries
  • Author : Sanaa M. Kamal
  • Publisher : Academic Press
  • Release : 23 November 2017
GET THIS BOOK Hepatitis C in Developing Countries

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health

HCV and Related Liver Diseases

HCV and Related Liver Diseases
  • Author : Kiwamu Okita
  • Publisher : Springer Science & Business Media
  • Release : 06 December 2012
GET THIS BOOK HCV and Related Liver Diseases

More than 2 million people in Japan have chronic hepatitis C and many of them will lose their lives to liver cirrhosis or complications of hepatocellular carcinoma. Hepatitis C virus-related diseases are a serious concern both in developing countries and in Japan and the United States, where the number of patients is also in the millions. Therapeutic modalities recently developed in Japan, including interferon therapy and nutritional supportive therapy, are gaining worldwide acceptance. At this critical juncture, HCV and Related Liver

Hepatitis C Virus NS3 NS5A and NS5B Proteins as Drug Targets

Hepatitis C Virus NS3  NS5A and NS5B Proteins as Drug Targets
  • Author : Mazhar Iqbal,Moazur Rahman,Anwar Muhammad Ikram,Muhammad Ikram Anwar
  • Publisher : LAP Lambert Academic Publishing
  • Release : 12 November 2014
GET THIS BOOK Hepatitis C Virus NS3 NS5A and NS5B Proteins as Drug Targets

Hepatitis C virus (HCV) infects 3% of world population with significant mortalities in developing countries. If HCV disease goes untreated, it can lead to cirrhosis, hepatocellular carcinoma and ultimately death of the patient. Currently in Pakistan, about 5 to 10% of population is infected with HCV. This book provides useful informations about diagnostic, prevalence and drug discovery initiative against HCV genotype-3a (HCV-3a), the most prevalent genotype in developing world, particularly in South Asia including Pakistan. Drug discovery imitative is pursued by

Modulation of Cell Proliferation Pathways by the Hepatitis B Virus X Protein A Potential Contributor to the Development of Hepatocellular Carcinoma

Modulation of Cell Proliferation Pathways by the Hepatitis B Virus X Protein  A Potential Contributor to the Development of Hepatocellular Carcinoma
  • Author : Jessica C. Casciano
  • Publisher : Unknown
  • Release : 17 September 2021
GET THIS BOOK Modulation of Cell Proliferation Pathways by the Hepatitis B Virus X Protein A Potential Contributor to the Development of Hepatocellular Carcinoma

Modulation of Cell Proliferation Pathways by the Hepatitis B Virus X Protein: A Potential Contributor to the Development of Hepatocellular Carcinoma.

Guidelines for the Screening Care and Treatment of Persons with Hepatitis C Infection

Guidelines for the Screening Care and Treatment of Persons with Hepatitis C Infection
  • Author : World Health Organization
  • Publisher : Unknown
  • Release : 31 March 2015
GET THIS BOOK Guidelines for the Screening Care and Treatment of Persons with Hepatitis C Infection

These are the first guidelines dealing with hepatitis C treatment produced by the World Health Organization (WHO) and complement existing guidance on the prevention of transmission of bloodborne viruses, including HCV. They are intended for policy-makers, government officials, and others working in low- and middleincome countries who are developing programmes for the screening, care and treatment of persons with HCV infection. These guidelines serve as a framework that can allow the expansion of clinical services to patients with HCV infection,

Vital Research in Hepatocellular Carcinoma

Vital Research in Hepatocellular Carcinoma
  • Author : Jay Amsel
  • Publisher : Unknown
  • Release : 10 January 2015
GET THIS BOOK Vital Research in Hepatocellular Carcinoma

Research-focused information regarding hepatocellular carcinoma has been illustrated in this all-inclusive book. Hepatocellular Carcinoma is a leading cause of cancer death and an important health problem in developing countries where hepatitis B infection is widespread. It has also gained significance with increase in hepatitis C infection in developed countries. Information on hepatocellular carcinoma has developed rapidly. This book is a well detailed publication produced as a result of the efforts of professionals and discusses the most updated information on hepatocellular

Hepatocellular Carcinoma

Hepatocellular Carcinoma
  • Author : Joseph W.Y. Lau
  • Publisher : IntechOpen
  • Release : 10 February 2012
GET THIS BOOK Hepatocellular Carcinoma

Hepatocellular Carcinoma represents a leading cause of cancer death and a major health problem in developing countries where hepatitis B infection is prevalent. It has also become increasingly important with the increase in hepatitis C infection in developed countries. Knowledge of hepatocellular carcinoma has progressed rapidly. This book is a compendium of papers written by experts to present the most up-to-date knowledge on hepatocellular carcinoma. This book deals mainly with the basic research aspect of hepatocellular carcinoma. The book is

Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine

Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
  • Author : Steven K.H. Foung,Thomas F. Baumert
  • Publisher : Frontiers Media SA
  • Release : 22 January 2019
GET THIS BOOK Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine

More than 70 million people worldwide are infected with hepatitis C virus, a major cause of liver cirrhosis, liver failure and hepatocellular carcinoma world-wide. In the last decade, this cancer has emerged as the second leading cause of cancer death and the global burden is increasing by two million new infections per year, mainly due to injection drug use. An effective vaccine will be the most effective means to contain the spread of this virus worldwide. The articles in this Research

Hepatocellular Carcinoma

Hepatocellular Carcinoma
  • Author : Joseph W.Y. Lau
  • Publisher : BoD – Books on Demand
  • Release : 10 February 2012
GET THIS BOOK Hepatocellular Carcinoma

Hepatocellular Carcinoma represents a leading cause of cancer death and a major health problem in developing countries where hepatitis B infection is prevalent. It has also become increasingly important with the increase in hepatitis C infection in developed countries. Knowledge of hepatocellular carcinoma has progressed rapidly. This book is a compendium of papers written by experts to present the most up-to-date knowledge on hepatocellular carcinoma. This book deals mainly with the basic research aspect of hepatocellular carcinoma. The book is

Hepatitis B C Infection Among Voluntary Blood Donors

Hepatitis B   C Infection Among Voluntary Blood Donors
  • Author : Omosigho Omoruyi Pius
  • Publisher : LAP Lambert Academic Publishing
  • Release : 01 January 2013
GET THIS BOOK Hepatitis B C Infection Among Voluntary Blood Donors

In many developing countries, the relative contribution of various routes of blood borne hepatitis infection have not been defined in population based studies due to lack of universal and appropriate blood screening policy in these countries the risk of post-transfusion hepatitis infection is still very high. This study was carried out to determine the seroprevalence of blood borne hepatitis B & C among blood donors by Rapid Chromatogenic Enzyme Immunoassay (EIA). One hundred and ninety eight (198) samples were collected from blood

Validation of a Protein Biomarker Panel for Early Hepatocellular Carcinoma Detection at the Point of Care

Validation of a Protein Biomarker Panel for Early Hepatocellular Carcinoma Detection at the Point of Care
  • Author : Elaine Ng
  • Publisher : Unknown
  • Release : 17 September 2021
GET THIS BOOK Validation of a Protein Biomarker Panel for Early Hepatocellular Carcinoma Detection at the Point of Care

Hepatocellular carcinoma (HCC) composes about 80% of liver cancer cases, which is the second leading cause of cancer-related deaths worldwide. Majority of HCC burden is present in developing countries where hepatitis B virus (HBV) vaccination is inadequate and transmission of hepatitis C virus (HCV) is prevalent. In addition, HCC is an escalating problem in the US where liver cancer rates doubled over the last three decades due to chronic HCV infection, diabetes, and obesity. Most patients become chronically infected, progress to